$0.09 Earnings Per Share Expected for Israel Chemicals Ltd (ICL) This Quarter

Wall Street brokerages forecast that Israel Chemicals Ltd (NYSE:ICL) will report earnings of $0.09 per share for the current quarter, Zacks Investment Research reports. Zero analysts have made estimates for Israel Chemicals’ earnings. Israel Chemicals posted earnings per share of $0.11 in the same quarter last year, which suggests a negative year-over-year growth rate of 18.2%. The company is expected to report its next quarterly earnings report on Wednesday, February 13th.

On average, analysts expect that Israel Chemicals will report full-year earnings of $0.37 per share for the current year. For the next year, analysts anticipate that the business will post earnings of $0.38 per share. Zacks Investment Research’s earnings per share averages are a mean average based on a survey of analysts that that provide coverage for Israel Chemicals.

Israel Chemicals (NYSE:ICL) last announced its quarterly earnings data on Thursday, November 1st. The basic materials company reported $0.10 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $0.09 by $0.01. The company had revenue of $1.37 billion for the quarter, compared to analysts’ expectations of $1.38 billion. Israel Chemicals had a net margin of 23.84% and a return on equity of 13.67%. The business’s revenue was down 4.8% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.09 EPS.

Several brokerages have recently issued reports on ICL. Zacks Investment Research raised shares of Israel Chemicals from a “sell” rating to a “hold” rating in a research note on Tuesday, October 30th. Jefferies Financial Group reaffirmed a “hold” rating and issued a $6.57 price objective on shares of Israel Chemicals in a research note on Sunday, October 21st. ValuEngine raised shares of Israel Chemicals from a “hold” rating to a “buy” rating in a research note on Friday, August 24th. Finally, BMO Capital Markets reaffirmed a “hold” rating and issued a $5.25 price objective on shares of Israel Chemicals in a research note on Wednesday, September 19th. Three investment analysts have rated the stock with a hold rating and two have issued a buy rating to the company’s stock. Israel Chemicals currently has a consensus rating of “Hold” and an average price target of $5.69.

Shares of ICL traded down $0.04 during mid-day trading on Friday, hitting $6.44. The company’s stock had a trading volume of 224,621 shares, compared to its average volume of 224,791. The stock has a market capitalization of $8.26 billion, a P/E ratio of 20.77, a P/E/G ratio of 1.88 and a beta of 1.07. The company has a debt-to-equity ratio of 0.44, a current ratio of 1.34 and a quick ratio of 0.73. Israel Chemicals has a fifty-two week low of $3.85 and a fifty-two week high of $6.90.

The company also recently announced a quarterly dividend, which will be paid on Wednesday, December 19th. Stockholders of record on Tuesday, December 4th will be given a $0.051 dividend. This is an increase from Israel Chemicals’s previous quarterly dividend of $0.04. This represents a $0.20 annualized dividend and a dividend yield of 3.17%. The ex-dividend date is Monday, December 3rd. Israel Chemicals’s dividend payout ratio (DPR) is 32.26%.

Institutional investors have recently added to or reduced their stakes in the company. Lourd Capital LLC purchased a new position in shares of Israel Chemicals in the third quarter worth approximately $167,000. AXA purchased a new position in shares of Israel Chemicals in the third quarter worth approximately $181,000. Janus Henderson Group PLC purchased a new position in shares of Israel Chemicals in the third quarter worth approximately $201,000. Eqis Capital Management Inc. purchased a new position in shares of Israel Chemicals in the second quarter worth approximately $245,000. Finally, BlackRock Inc. increased its position in shares of Israel Chemicals by 13.9% in the first quarter. BlackRock Inc. now owns 113,993 shares of the basic materials company’s stock worth $483,000 after acquiring an additional 13,942 shares in the last quarter. 8.10% of the stock is currently owned by institutional investors and hedge funds.

About Israel Chemicals

Israel Chemicals Ltd. operates as a specialty minerals company worldwide. The company operates through two segments, Essential Minerals and Specialty Solutions. The company extracts potash from the Dead Sea; mines and produces potash, salt, and Polysulphate; and produces, markets, and sells pure magnesium and magnesium alloys, as well as produces dry carnallite and related by-products, including chlorine and sylvinite.

Featured Story: Retained Earnings

Get a free copy of the Zacks research report on Israel Chemicals (ICL)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for Israel Chemicals (NYSE:ICL)

Receive News & Ratings for Israel Chemicals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Israel Chemicals and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply